Summa Equity Fund II (Summa) has acquired a majority stake in G-CON, a leading US-based manufacturer of prefabricated cleanrooms used for manufacturing within the pharmaceuticals industry. G-CON designs, builds and installs turnkey cGMP (Current Good Manufacturing Practice) compliant suites called PODs, for a global biopharma customer base focused on biologics,
Spendesk, an all-in-one spend management platform for finance teams, has raised EUR100 million in Series C funding led by global growth equity firm General Atlantic. All previous investors, including Index Ventures and Eight Roads Ventures, also participated in this round, bringing Spendesk’s total funding to EUR160 million. With the additional
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in eMindful, a provider of evidence-based, mindfulness programmes for everyday life and chronic conditions. The investment is an add-on to Riverside’s Wondr Health (formerly Naturally Slim), a digital behavioral change company focused
Global Venture Capital (VC) investors continue to deploy record amounts of money into UK scaleups with nearly GBP17 billion raised in the first half of 2021. This already surpasses the total sum raised in the whole of last year according to Venture Pulse – a quarterly report published by KPMG
Strong equity markets, and increased demand for transformational, disruptive tech businesses, saw valuations and deal volumes, soar in the first half of 2021, says tech-focussed investment bank ICON Corporate Finance. As the market responded to the volatility of 2020, ICON’S UK Tech M&A Snapshot reveals that a record number of
FTX Trading (FTX.COM), the owner and operator of the FTX.COM cryptocurrency exchange, has closed a USD900 million Series B fundraise, valuing the Company at USD18 billion. This new financing round will expand FTX’s global presence, accelerate the Company’s growth, and represents one of the largest raises for a crypto company.
Coave Therapeutics, a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases, has raised an additional EUR21.2 million (USD25.1 million) of Series B funding, bringing the total raised to EUR33.1 million (USD39 million). This latest financing was led by
Aromyx, a specialist in applying biotechnology and data science to capture unique sensory data, has closed an oversubscribed USD10 million Series A round of financing led by Rabo Food&Ag Innovation Fund and SOZO Ventures. Existing investors Ulu Ventures, Radicle Growth, Capital Energy and Merus Capital also participated in the round.
Anzu Partners, an investment firm that focuses on early stage industrial and life science technology companies, has launched its third venture fund with USD130 million in commitments to date toward a USD300 million target size. Anzu’s Fund III will invest in early-stage breakthrough technology companies that can shape and enable
Speedinvest, a pan-European early-stage VC, today announces the final closing of its second specialist marketplaces and consumer fund at EUR60 million, above its original target of EUR50 million. More than a dozen notable marketplace founders and executives have joined the final close, including the founders of Ankorstore, Vinted, TradingView, Planetly,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
